Back

Marked differences in ICD therapy frequencies between phenotypes

28 August 2023 (12:10 - 12:20)
Organised by: Logo
Congress Presentation Part of: Recent advances in implantable cardioverter defibrillator therapy Implantable Cardioverter-Defibrillator (ICD) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Chaoqun Zheng

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Chronic safety and performance of the extravascular ICD: results from the global EV ICD Pivotal study
Professor L. Boersma (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Subcutaneous versus transvenous ICDs: a population-level comparison of incidence, patient characteristics, and complications of S-ICDs, ICDs, and CRT-Ds in a nationwide Dutch cohort (2018-2020)
Assistant Professor M. Samuel (Pittsburgh, US)
Abstract Slides Video
Presentation thumbnail
Local anesthesia during S-ICD implantation gives similar post procedural pain perception as sedation
Ms J. De Veld (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Real world battery longevity of the subcutaneous implantable cardioverter-defibrillator (S-ICD)
Miss W. van der Stuijt (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes of primary prophylactic use of defibrillators with ischemic and non-ischemic cardiomyopathy: propensity score-matched analysis from NIPPON STORM Study
Associate Professor Y. Kondo (Chiba, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Recent advances in implantable cardioverter defibrillator therapy
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 12:10 CET
You may be interested in
thumbnail
Congress Presentation
Long-term follow-up in patients with hypertrophic cardiomyopathy after defibrillator implantation: analysis of appropriate and inappropriate therapy
thumbnail
Congress Session
Recent advances in implantable cardioverter defibrillator therapy
thumbnail
Congress Presentation
Primary prevention implantable cardioverter defibrillators are no longer indicated in non-ischaemic HFrEF: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources